Percepta Launches Life Science Dashboard™
Market Research Reports for Purification, Amplification & Transfection
New Market Research Reports Reveal Key Indicators in Molecular
Biology Reagent Markets
CARLSBAD, Calif. (Business Wire EON/PRWEB ) February 17, 2007 --
Percepta
Associates (http://www.perceptaassociates.com/index.shtml),
a market research and strategic consulting firm focused on serving
molecular biology and cell biology companies, announced today the launch
of its Life Science
Dashboards™ (http://www.perceptaassociates.com/publications/life_science_
dashboard.shtml) series of segment-specific market research reports.
The Life Science Dashboards™ are readily
accessible sources of current, segment-specific, market research.
Designed and implemented by industry veterans, each dashboard provides
key life science market indicators compiled from the survey responses of
hundreds of qualified decision-makers and researchers actively using
molecular biology and cell culture products.
Unlike other market research reports, Percepta's dashboards feature an
at a glance format that provides rapid access to actionable key market
indicators in an easy to understand framework, including:
-
Market size
-
Market share
-
Market growth and reaction throughput rates
-
Customer satisfaction
-
Propensity to switch
-
Competitive intensity
-
Perceived pricing
-
Top suppliers
-
Technique usage frequency
-
Fastest growing techniques
-
Primary and secondary downstream applications
“We recognize that professionals in bioscience
tools companies need timely, relevant and practical market research as a
fact-based foundation for decision making," said Mike Klein, Principal
of Percepta. “That’s
hard to find in this industry, so we developed these life science
indicator dashboards.”
The
Nucleic Acid Purification Dashboard (http://www.perceptaassociates.com/publications/nucleic_acid_p_
overview.shtml) reveals that Qiagen (NASDAQ:QGEN), Invitrogen
(NASDAQ:IVGN), Promega and Ambion (NASDAQ:ABI) each hold
strong segment-specific positions in this market. Embryonic segments,
such as microRNA purification, show the greatest growth potential in
coming years.
The
Nucleic Acid Amplification Dashboard (http://www.perceptaassociates.com/publications/nucleic_acid_a_
overview.shtml) reveals that top suppliers for PCR and RNA
amplification segments such as Applied Biosystems (NASDAQ:ABI),
Invitrogen (NASDAQ:IVGN), Promega and Stratagene
(NASDAQ:STGN) face competitive pressure from Qiagen
(NASDAQ:QGEN), New England Biolabs and others.
The
Transfection Dashboard (http://www.perceptaassociates.com/publications/transfection_
overview.shtml) reveals that Invitrogen (NASDAQ:IVGN), Bio-Rad
(AMEX:BIO), Roche (VTX:ROG.VX), Qiagen (NASDAQ:QGEN) and Sigma
(NASDAQ:SIAL) are the market leaders. Customer interest in switching
suppliers is relatively high, particularly for lipid-based transfection
reagents.
Additional dashboards to be launched in the first series include:
Percepta launched this initial series of molecular biology and cell
culture dashboard-based market research reports to take a snapshot of
the current market landscape, with the future goal of regular market
sampling to give dashboard readers a comprehensive, relevant and dynamic
view on how the market is adapting to new products, new competitors and
new sales and marketing strategies.
Click
here to view market research sample data and questionnaires (http://www.perceptaassociates.com/publications/nucleic_acid_a_
overview.shtml).
About Percepta
(http://www.perceptaassociates.com/index.shtml)
Founded in 2005 in Carlsbad, Percepta Associates serves an impressive
and rapidly growing roster of bioscience clients across North America
and Europe. Percepta is a specialized consultancy providing expert
market research, strategic business planning, portfolio management,
product and corporate branding and marketing communications services.
Unlike other consultants, Percepta's seasoned associates have a proven
track record of leadership in life science supply companies. For more
information visit www.perceptaassociates.com.
(Due to their lengths, some of the URLs in this press release may need
to be copied/pasted into your Internet browser's address field. Remove
the extra spaces if any exist.)
Optimized by Newsforce
See the original story at: http://eon.businesswire.com/releases/market/dashboard/prweb505734.htm
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1UaGlyLU1hZ24tSG9yci1NYWduLVplcm8=
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
